The CyberKnife system is a non-invasive, robotic radiation therapy technology used to treat cancerous and non-cancerous tumors, as well as other medical conditions.
It delivers highly precise, high-dose radiation while minimizing exposure to surrounding healthy tissues.
It targets tumors with sub-millimeter accuracy using real-time imaging and robotic technology, even accounting for patient movement, such as breathing.
It is non-Invasive.
It can treat tumors in hard-to-reach areas like the brain, spine, lungs, liver, and pancreas, including those previously deemed inoperable.
It rReduces radiation exposure to healthy tissues and can safely treat areas that have already undergone radiation therapy.
Treatment is typically completed in 1–5 sessions compared to weeks of traditional radiation therapy.
The robotic arm delivers radiation from multiple angles.
Each session lasts 30–90 minutes and is performed on an outpatient basis with minimal recovery time.
CyberKnife is a cutting-edge option for patients seeking effective and precise treatment with fewer side effects compared to conventional therapies.
CyberKnife radiation therapy is a form of stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT) that utilizes a robotic arm to deliver highly precise radiation doses to tumors throughout the body.
The CyberKnife system combines a linear accelerator mounted on a robotic arm with real-time image guidance to track and adjust for patient and tumor movement during treatment.
The system is unique in its ability to deliver radiation from hundreds of different angles, allowing for highly conformal dose distributions that spare surrounding healthy tissues. The system
This system uses a 6-MV linear accelerator and an imaging system that includes diagnostic x-ray sources and amorphous silicon detectors, enabling real-time tracking of tumors, even those that move with respiration.
CyberKnife is used to treat intracranial and spinal lesions, lung tumors, liver metastases, and prostate cancer, being beneficial for patients who are not suitable candidates for surgery due to its non-invasive nature and the precision with which it can target tumors.
CyberKnife can deliver hypofractionated radiation doses for lung cancer such as 25 Gy in 5 fractions, with high local control rates and minimal toxicity.
For spinal lesions, CyberKnife has been shown to be effective, safe and provides significant pain relief and tumor control without the need for rigid immobilization.